INS and posterior cortical atrophy: Among both users of insulin (N = 501) and non‐users (N = 1471), metformin users had significantly lower risks of PCa‐related mortality and all‐cause mortality (p value for interaction = 0.642 and 0.384, respectively; Supporting Information: Table 6).